Crosstalk between the Producers and Immune Targets of IL-9
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
IL-9 has been reported to play dual roles in the pathogenesis of autoimmune disorders and cancers. The collaboration of IL-9 with microenvironmental factors including the broader cytokine milieu and other cellular components may provide important keys to explain its conflicting effects in chronic conditions. In this review, we summarize recent findings on the cellular sources of, and immunological responders to IL-9, in order to interpret the role of IL-9 in the regulation of immune responses. This knowledge will provide new perspectives to improve clinical benefits and limit adverse effects of IL-9 when treating pathologic conditions.
Abstract
IL-9 has been reported to play dual roles in the pathogenesis of autoimmune disorders and cancers. The collaboration of IL-9 with microenvironmental factors including the broader cytokine milieu and other cellular components may provide important keys to explain its conflicting effects in chronic conditions. In this review, we summarize recent findings on the cellular sources of, and immunological responders to IL-9, in order to interpret the role of IL-9 in the regulation of immune responses. This knowledge will provide new perspectives to improve clinical benefits and limit adverse effects of IL-9 when treating pathologic conditions.
참고문헌 (99)
- Uyttenhove C, "Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity", Proc Natl Acad Sci U S A, 85, pp.6934~6938 (1988)
- Renauld JC, "Expression cloning of the murine and human interleukin 9 receptor cDNAs", Proc Natl Acad Sci U S A, 89, pp.5690~5694 (1992)
- Noelle RJ, "Cellular sources and immune functions of interleukin-9", Nat Rev Immunol, 10, pp.683~687 (2010)
- Chakraborty S, "An update on interleukin-9 : from its cellular source and signal transduction to its role in immunopathogenesis", Int J Mol Sci, 20, pp.2113~ (2019)
- Demoulin JB, "Role of insulin receptor substrate-2 in interleukin-9-dependent proliferation", FEBS Lett, 482, pp.200~204 (2000)
- Demoulin JB, "MAP kinase activation by interleukin-9 in lymphoid and mast cell lines", Oncogene, 22, pp.1763~1770 (2003)
- Ciccia F, "Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis", Rheumatology(Oxford), 54, pp.2264~2272 (2015)
- Li H, "IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system", Eur J Immunol, 41, pp.2197~2206 (2011)
- Deng Y, "Th9 cells and IL-9 in autoimmune disorders : pathogenesis and therapeutic potentials", Hum Immunol, 78, pp.120~128 (2017)
- Yoshimura S, "IL-9 controls central nervous system autoimmunity by suppressing GM-CSF production", J Immunol, 204, pp.531~539 (2020)
- Elyaman W, "Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells", Immunity, 36, pp.623~634 (2012)
- Wan J, "HMGB1-induced ILC2s activate dendritic cells by producing IL-9 in asthmatic mouse model", Cell Immunol, 352, pp.104085~ (2020)
- Verma M, "Experimental asthma persists in IL-33receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+and IL13+type 2 innate lymphoid cell subpopulations", J Allergy Clin Immunol, 142, pp.793~803 (2018)
- Sun B, "Characterization and allergic role of IL-33-induced neutrophil polarization", Cell Mol Immunol, 15, pp.782~793 (2018)
- Liu J, "IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis", J Invest Dermatol, 134, pp.1903~1911 (2014)
- Fawaz LM, "Expression of IL-9 receptor αchain on human germinal center B cells modulates IgE secretion", J Allergy Clin Immunol, 120, pp.1208~1215 (2007)
- Townsend JM, "IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development", Immunity, 13, pp.573~583 (2000)
- Eller K, "IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression", J Immunol, 186, pp.83~91 (2011)
- Lu LF, "Mast cells are essential intermediaries in regulatory T-cell tolerance", Nature, 442, pp.997~1002 (2006)
- Lee JE, "The role of interleukin-9 in cancer", Pathol Oncol Res, 26, pp.2017~2022 (2020)
- Wan J, "IL-9 and IL-9-producing cells in tumor immunity", Cell Commun Signal, 18, pp.50~ (2020)
- Veldhoen M, "Transforming growth factor-β ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset", Nat Immunol, 9, pp.1341~1346 (2008)
- Dardalhon V, "IL-4 inhibits TGF-β-induced Foxp3+T cells and, together with TGF-β, generates IL-9+IL-10+Foxp3-effector T cells", Nat Immunol, 9, pp.1347~1355 (2008)
- Kaplan MH, "The transcription factor network in Th9 cells", Semin Immunopathol, 39, pp.11~20 (2017)
- Zhou Y, "IL-9promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes", J Immunol, 186, pp.4415~4421 (2011)
- Koh B, "The ETS family transcription factors ETV5 and PU. 1 function in parallel to promote Th9 cell development", J Immunol, 197, pp.2465~2472 (2016)
- You FP, "Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer", Int Immunopharmacol, 52, pp.163~167 (2017)
- Ulrich BJ, "STAT3 activation impairs the stability of Th9cells", J Immunol, 198, pp.2302~2309 (2017)
- Rampal R, "Retinoic acid-primed human dendritic cells inhibit Th9 cells and induce Th1", Th17 cell differentiation, 2016, pp.100, 111~120
- Murugaiyan G, "IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27", J Immunol, 189, pp.5277~5283 (2012)
- Xue G, "IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling", Nat Commun, 10, pp.1376~ (2019)
- Kim IK, "Glucocorticoidinduced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells", Nat Med, 21, pp.1010~1017 (2015)
- Moretti S, "A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis", Nat Commun, 8, pp.14017~ (2017)
- Tesmer LA, "Th17 cells in human disease", Immunol Rev, 223, pp.87~113 (2008)
- Beriou G, "TGF-β induces IL-9 production from human Th17 cells", J Immunol, 185, pp.46~54 (2010)
- Elyaman W, "IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+natural regulatory T cells", Proc Natl Acad Sci U S A, 106, pp.12885~12890 (2009)
- Nowak EC, "Interleukin-9 as a T helper type 17 cytokine", Immunology, 131, pp.169~173 (2010)
- Thomas LS, "The TNF family member TL1A induces IL-22 secretion in committed human Th17 cells via IL-9 induction", J Leukoc Biol, 101, pp.727~737 (2017)
- Cosmi L, "Identification of a novel subset of human circulating memory CD4+T cells that produce both IL-17A and IL-4", J Allergy Clin Immunol, 125, pp.222~230 (2010)
- Singh TP, "Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis", PLoS One, 8, pp.e51752~ (2013)
- Kebir H, "Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation", Nat Med, 13, pp.1173~1175 (2007)
- Nowak EC, "IL-9 as a mediator of Th17-driven inflammatory disease", J Exp Med, 206, pp.1653~1660 (2009)
- 김영상, "Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells", Immune Network, 18(1), pp.1~16 (2018), 대한면역학회[DOI]
- Purwar R, "Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells", Nat Med, 18, pp.1248~1253 (2012)
- Adeegbe DO, "Natural and induced T regulatory cells in cancer", Front Immunol, 4, pp.190~ (2013)
- Whiteside TL, "Induced and natural regulatory T cells in human cancer", Expert Opin Biol Ther, 12, pp.1383~1397 (2012)
- Feng LL, "IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma", J Clin Immunol, 31, pp.1084~1094 (2011)
- Smith SE, "Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses", Cancer Immunol Immunother, 60, pp.1775~1787 (2011)
- Yao Z, "Nonredundant roles for Stat5a", b in directly regulating Foxp3, 2007, pp.109, 4368~4375
- Laurence A, "Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation", Immunity, 26, pp.371~381 (2007)
- Jacobson NG, "Interleukin 12 signaling in T helper type 1(Th1)cells involves tyrosine phosphorylation of signal transducer and activator of transcription(Stat)3 and Stat4", J Exp Med, 181, pp.1755~1762 (1995)
- Wu B, "IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis", Clin Immunol, 126, pp.202~210 (2008)
- Lu Y, "Tumor-specific IL-9-producing CD8+ Tc9cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers", Proc Natl Acad Sci U S A, 111, pp.2265~2270 (2014)
- Visekruna A, "Tc9 cells, a new subset of CD8(+)T cells, support Th2-mediated airway inflammation", Eur J Immunol, 43, pp.606~618 (2013)
- Liu N, "IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells", Cell Mol Immunol, 16, pp.644~651 (2019)
- Chang SY, "Circulatory antigen processing by mucosal dendritic cells controls CD8(+)T cell activation", Immunity, 38, pp.153~165 (2013)
- Ding P, "IL-9-producing CD8+T cells represent a distinctive subset with different transcriptional characteristics from conventional CD8+T cells, and partially infiltrate breast tumors", Int J Biochem Cell Biol, 115, pp.105576~ (2019)
- Ma X, "Cholesterol negatively regulates IL-9-producing CD8+T cell differentiation and antitumor activity", J Exp Med, 215, pp.1555~1569 (2018)
- Wang C, "Th9 cells are subjected to PD-1", PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer, 2020, pp.78, 106019~
- Nonomura Y, "Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients", OncoImmunology, 5, pp.e1248327~ (2016)
- Wang Y, "Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells", Nat Immunol, 18, pp.921~930 (2017)
- Takatsuka S, "IL-9 receptor signaling in memory B cells regulates humoral recall responses", Nat Immunol, 19, pp.1025~1034 (2018)
- Lv X, "Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma", J Exp Clin Cancer Res, 35, pp.106~ (2016)
- Vink A, "Interleukin 9-induced in vivo expansion of the B-1lymphocyte population", J Exp Med, 189, pp.1413~1423 (1999)
- Chen J, "Dectin-1-activated dendritic cells : a potent Th9 cell inducer for tumor immunotherapy", OncoImmunology, 5, pp.e1238558~ (2016)
- Chen J, "Interleukin-33contributes to the induction of Th9 cells and antitumor efficacy by dectin-1-activated dendritic cells", Front Immunol, 9, pp.1787~ (2018)
- Zhao Y, "Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells", Nat Commun, 7, pp.12368~ (2016)
- Donninelli G, "Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain", J Neuroinflammation, 17, pp.149~ (2020)
- Park J, "Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy", Cancer Immunol Immunother, 63, pp.835~845 (2014)
- Leech MD, "Induction of enhanced immunity to intestinal nematodes using IL-9-producing dendritic cells", J Immunol, 176, pp.2505~2511 (2006)
- Spits H, "Innate lymphoid cells : emerging insights in development, lineage relationships, and function", Annu Rev Immunol, 30, pp.647~675 (2012)
- Vivier E, "Innate lymphoid cells : 10 years on", Cell, 174, pp.1054~1066 (2018)
- Wilhelm C, "An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation", Nat Immunol, 12, pp.1071~1077 (2011)
- Mohapatra A, "Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis", Mucosal Immunol, 9, pp.275~286 (2016)
- Turner JE, "IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation", J Exp Med, 210, pp.2951~2965 (2013)
- Price AE, "Systemically dispersed innate IL-13-expressing cells in type 2 immunity", Proc Natl Acad Sci U S A, 107, pp.11489~11494 (2010)
- Hoyler T, "The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells", Immunity, 37, pp.634~648 (2012)
- Roediger B, "IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation", J Allergy Clin Immunol, 136, pp.1653~1663 (2015)
- Stassen M, "Murine bone marrowderived mast cells as potent producers of IL-9 : costimulatory function of IL-10 and kit ligand in the presence of IL-1", J Immunol, 164, pp.5549~5555 (2000)
- Koh B, "A conserved enhancer regulates Il9 expression in multiple lineages", Nat Commun, 9, pp.4803~ (2018)
- Hültner L, "In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9", J Immunol, 164, pp.5556~5563 (2000)
- Abdul Qayum A, "The IL9 CNS-25 regulatory element controls mast cell and basophil IL-9 production", J Immunol, 203, pp.1111~1121 (2019)
- Reitz M, "Interleukin-9 promotes early mast cell-mediated expulsion of Strongyloides ratti but is dispensable for generation of protective memory", Sci Rep, 8, pp.8636~ (2018)
- Jones TG, "Antigeninduced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells", J Immunol, 183, pp.5251~5260 (2009)
- Chen CY, "Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy", Immunity, 43, pp.788~802 (2015)
- Yin JJ, "Neutralization of interleukin-9 decreasing mast cells infiltration in experimental autoimmune encephalomyelitis", Chin Med J(Engl), 130, pp.964~971 (2017)
- Wiener Z, "IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice", Cytokine, 26, pp.122~130 (2004)
- Renga G, "IL-9 and mast cells are key players of candida albicans commensalism and pathogenesis in the gut", Cell Reports, 23, pp.1767~1778 (2018)
- Tete S, "Interleukin-9 and mast cells", J Biol Regul Homeost Agents, 26, pp.319~326 (2012)
- 이지붕, "Regulation of IgE-Mediated Food Allergy by IL-9 Producing Mucosal Mast Cells and Type 2 Innate Lymphoid Cells", Immune Network, 16(4), pp.211~218 (2016), 대한면역학회[DOI]
- Godfraind C, "Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice", J Immunol, 160, pp.3989~3996 (1998)
- Monteiro M, "IL-9 expression by invariant NKT cells is not imprinted during thymic development", J Immunol, 195, pp.3463~3471 (2015)
- Nagato T, "Expression of interleukin-9 in nasal natural killer", T-cell lymphoma cell lines and patients, 2005, pp.11, 8250~8257
- Peters C, "Human Vδ2 T cells are a major source of interleukin-9", Proc Natl Acad Sci U S A, 113, pp.12520~12525 (2016)
- Guggino G, "Interleukin(IL)-9", IL-9R axis drives γδ T cells activation in psoriatic arthritis patients, 2016, pp.186, 277~283
- Gounni AS, "IL-9 expression by human eosinophils : regulation by IL-1β and TNF-α", J Allergy Clin Immunol, 106, pp.460~466 (2000)
- 박상민, "Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-Tumor M1 Macrophages", Molecules and Cells, 43(5), pp.479~490 (2020), 한국분자세포생물학회[DOI]
- Ross SH, "Signaling and function of interleukin-2 in T lymphocytes", Annu Rev Immunol, 36, pp.411~433 (2018)
- Bachmann MF, "Interleukin 2 : from immunostimulation to immunoregulation and back again", EMBO Rep, 8, pp.1142~1148 (2007)
